Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Veverimer to Decrease Net Acid Excretion and Bone Resorption in Adults With Osteopenia: a Dose-finding Randomized Controlled Trial

NCT07473713 is registered in ClinicalTrials.gov with Tufts Medical Center as lead sponsor.

NCT NCT07473713
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07473713 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Veverimer to Decrease Net Acid Excretion and Bone Resorption in Adults With Osteopenia: a Dose-finding Randomized Controlled Trial
Lead sponsor
Tufts Medical Center
Phase
Phase 1
Overall status
Recruiting
Start date
April 15, 2026
Completion date
May 1, 2028
Enrollment
60 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

osteopenia